Replacing the Merit-based Incentive Payment System (MIPS) with a voluntary program should encourage providers to move quicker into more risk-based payment models, according to Travis Broome, vice president for policy at Aledade.
Replacing the Merit-based Incentive Payment System (MIPS) with a voluntary program should encourage providers to move quicker into more risk-based payment models, according to Travis Broome, vice president for policy at Aledade.
In January, the Medicare Payment Advisory Commission (MedPAC) had voted on repealing MIPS, which was established under the Medicare Access and CHIP Reauthorization Act (MACRA), and replacing it with the Voluntary Value Program (VVP). Under MACRA, physicians caring for Medicare patients could get reimbursed by participating in 1 of 2 tracks: MIPS or an advanced alternative payment model (APM).
There were concerns about the structure of MIPS, and Broome believes that MedPAC is addressing 2 of those concerns: first, that too many providers will stay in a safe spot that only requires them to “check the box” or do the minimum on quality measurement without advancing to something with more risk; and second, the high burden of data collection in MIPS. Broome agrees with the sentiment that too many providers would be "hanging out in the middle" without moving to an advanced APM.
Another issue MedPAC had with MIPS was that in order to use claims-based data for reporting and measurement purposes, physicians who didn’t voluntarily join a virtual group or an accountable care organization were being automatically and randomly grouped with other physicians. The solution, then, had been to incentivize providers with VVP to voluntarily join those groups. Being forced into randomly generated groups had been a huge source of pushback from providers.
“They won’t feel connected enough to a random group like that to feel they should be graded on the group’s performance,” Broome said. “Whereas, when you join a group, you know what you’re signing up for.”
He noted, though, that no one expected MIPS was simply going to stay the same. Already, MIPS had evolved faster than expected, Broome said. For instance, CMS included cost as a measurement component for 2018 when most people expected they would get another year before it was added.
Broome was also skeptical about the reality of getting rid of MIPS entirely, since it would require legislative action from Congress.
“I don’t know if there’s going to be much interest in revisiting MACRA, something that was passed with such bipartisan support,” he said. “But I do think [MedPAC's vote] really will ... hopefully, push the administration to try and encourage providers to not stay in the measurement version of value-based care.”
Broome explained that he expects to see more from the current administration in terms of risk-based models, such as a total cost of care model that looks more like Medicare Advantage and some tweaks to the Medicare Shared Savings Program.
The fact that CMS Administrator Seema Verma has said she wants to see more providers take up risk-based advanced APMs and wants to incentivize that through better designs of models and making them more attractive to physicians—perhaps by reducing administration or financial burden—has provided a lot of hope for Broome regarding the future direction of value-based care.
Ultimately, he isn’t concerned with MedPAC's vote to get rid of MIPS, because the committee still wants the physicians to continue the move toward value-based care. Instead, he viewed the vote as indicating that MedPAC felt forcing physicians into more risk was going to result in them doing the minimum necessary to avoid a negative rate adjustment.
“If physicians buy into it, choose to do it, [that] is actually when you get the change where they’ll actually try to do something different with their practices in the future than they do today,” Broome said. “Whereas, if you force them into it, then there’s just checking boxes and doing a compliance exercise.”
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More